August 22, 2014: Boston is renowned for its top educational institutions and biotechnology firms, but there’s change in the air that can no longer be ignored. The city is evolving into a pharmaceutical hub and there’s good reason for it.
August 22, 2014: Pozen recently announced that that they are shifting their focus from R&D to licensing and distribution. As a result of this shift, the company plans to reduce its research and development staff.
August 22, 2014: IDA Ireland has been in talks with a multi-national pharmaceutical company for investment in the area of between €500 million to €1 billion.
August 22, 2014: The former chief executive of biotech business Phosphagenics, Esra Ogru, pleaded guilty today to stealing approximately $6.1 million from the company. Ogru, 39, was charged with six counts of obtaining a financial charge by deception.